Stay updated on Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The NIH site-transition notice about using “Super Intelligence” alongside “Artificial Intelligence” was removed from the banner at the top of the page.
    Difference
    1%
    Check dated 2026-11-08T04:38:33.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T01:43:59.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A notice announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T01:46:51.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:29:27.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:05:04.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error page, replacing the expected study content with a generic site layout. Users cannot view the trial details or related information until access is restored.
    Difference
    20%
    Check dated 2026-09-20T00:51:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page.